Plasma Collection. CBS agrees that all Plasma it collects in Canada for pickup by Supplier for fractionation by Supplier shall be collected, stored and transported in accordance with the Canadian Food and Drugs Act and the Drugs Directorate Guidelines on Blood Collection and Blood Component Manufacturing, 1992, established plasma specifications, and any amendments thereto, and in accordance with current import/export regulations. 6.1.1 Supplier will perform the B-19 Testing Services described in Schedule “I” at its Facility located in Raleigh, North Carolina (“Supplier Facility”), but may perform such Services at another location upon written notice to CBS.
Appears in 2 contracts
Sources: Contract Fractionation Services and Commercial Products Agreement (Talecris Biotherapeutics Holdings Corp.), Contract Fractionation Services and Commercial Products Agreement (Talecris Biotherapeutics Holdings Corp.)